[chart]investorshub.advfn.com/uimage/uploads/2017/6/28/lmzwbrabits.jpg[/chart]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ALKM 150k share sell @3 a whole $45 worth
ALKM Yep 2 days in a row 1,000 share paint down end of day.
I like that part
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently
anticipated or that occurred within the past 12 months:
Contemplating a reverse stock split of 1-for-8
ALKM Low Volume but all buys so far today.
https://ih.advfn.com/stock-market/USOTC/alkame-pk-ALKM/trades
ALKM Yes ALKM's own Tea is Brewing.
https://trademarks.justia.com/856/65/alkame-85665708.html?fbclid=IwAR0eAIJOtL6kfAcGn9I47qbuvUflPYweZwqWMzA-3j01KqtDZwZqOaraWYI
Bell Food & Beverage Inc.
August 9 ·
A whole new set of teas about to head into production after some pretty rigorous development. Test batch is up next and then they can launch! Very excited to see them on the home stretch.
NO 8-K after form 15 filing. It will be called an information statement on the OTCM
Guard Dog Provides Shareholder Update
2:14 PM ET 10/25/19 | GlobeNewswire
Guard Dog Provides Shareholder Update
BOULDER CITY, Nev., Oct. 25, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- George Sharp, President of Guard Dog, Inc. (PINKSHEETS: GRDO) announced today that the company's securities counsel is continuing to work with Nevada's office of the Secretary of State to unwind and correct past corporate actions, which if left as is would have made it impossible for the corporation to move forward with its plans. As a result of these past corporate actions, some going back as far as when the corporation was formed, the more recent actions initiated by current management also had to be unwound. Shareholders may notice a series of temporary changes to the number of authorized and outstanding shares, but once the required and proper corporate actions have been completed, these numbers will return to their expected state and the company will resume its application to FINRA for a name change and one for eight reverse split. Management expects all of this to be completed at some time during November.
The company's Starsona investment remains in the company's plans and a Definitive Agreement is expected to be executed once the company's corporate structure and capitalization has been finalized.
About Guard Dog, Inc.
Guard Dog is an opportunity investor seeking to finance fresh ideas. The company is headed by George Sharp, a longtime whistleblower and advocate against microcap fraud. In addition to consulting to public companies, attorneys and those associated with the financial markets, Mr. Sharp is a former consultant to OTC Markets Group, Inc.
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans, " "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.
CONTACT:
Guard Dog, Inc.
1022 Nevada Highway
Boulder City, NV 89005
702-840-4433
> Dow Jones Newswires
October 25, 2019 14:14 ET (18:14 GMT)
GRDO 10-Q: for Quarterly Period Ended 09/30/19 due Thursday, November 14, 2019
https://www.securexfilings.com/sec-deadlines/
GRDO it has only doubled
GRDO SECURITY DETAILS
Share Structure
Market Cap Market Cap
1,076,295
10/24/2019
Authorized Shares
2,430,500,000
10/02/2019
Outstanding Shares
2,152,589,568
10/02/2019
Restricted
10,950,072
10/02/2019
Unrestricted
2,141,639,496
10/02/2019
Held at DTC
1,398,761,441
10/02/2019
Float
2,141,639,496
06/30/2019
https://www.otcmarkets.com/stock/GRDO/security
GRDO lets go.
If there is NO R/S it is good. IMO
GRDO My guess is the R/S is called off. Had to raise the AS to make the deal still work. ALL IMO
ALKM $2 paint down. SMH HB.
ALKM Nice Webpage, good Job. http://bellcampus.com/
StemSpine(R) to Launch in the United States Following Successful Treatments Overseas with 12+ Months Data Showing Safety and Efficacy
8:45 AM ET 10/17/19 | Dow Jones
PHOENIX, Oct. 17, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today announced the successful clinical commercialization of StemSpine(R).
StemSpine(R), a patented procedure for the treatment of chronic lower back pain (CLBP) utilizing a patient's own stem cells, has successfully been implemented with the treatment of the first patients with over 12+ months of data showing safety and efficacy. The company plans to submit the results for publication in a peer reviewed journal imminently.
The company will begin commercializing StemSpine(R) in the US with the launch of a new website and physician recruitment in the weeks ahead. "As we've previously announced it was our goal to commercialize StemSpine(R) in 2019, so we're pleased with the progress of this technology and the value it brings to our company as domestic commercialization begins," said Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc.
"StemSpine(R) will surely be welcomed by the over 50 million Americans suffering from CLBP in the United States as a drug free alternative. Currently, there are minimal treatment options for patients that suffer from this debilitating pain, with roughly 50% of patients progressing to opioids and surgery,(1) " said Thomas Ichim PhD, Chief Scientific Officer of Creative Medical Technology Holdings, Inc. and patent inventor.
About Chronic Lower Back Pain:
Chronic lower back pain represents a leading cause of disability worldwide and is the most common non-cancer reason for opioid prescription in the U.S. It affects up to 30% of U.S. adults and is estimated to cost the U.S. healthcare system over $100 billion each year.
Forward-Looking Statements
OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov.
(1) https://healthcare.utah.edu/publicaffairs/news/2019/10/heal-initiative.php
View original content to download multimedia:http://www.prnewswire.com/news-releases/stemspine-to-launch-in-the-united-states-following-successful-treatments-overseas-with-12-months-data-showing-safety-and-efficacy-300940385.html
SOURCE Creative Medical Technology Holdings, Inc.
/CONTACT: Timothy Warbington, CEO, ceo@creativemedicalhealth.com
/Web site: https://creativemedicaltechnology.com/
> Dow Jones Newswires
October 17, 2019 08:45 ET (12:45 GMT)
ARYC UP UP and Away never said a rock a stock. LOL Green Is Very Good
ALKM Lookin Good Boss. http://bellcampus.com/
LOL I know. :) 10/14/19 6922 Stock/ETF
Buy — ALKM — — — 48 0.0004 Executed
I am sure all those 80K sells today was to incite a sell off Finns on the way and Our own Tea For ALKM
Might be a short day, I haven't looked. That is just what TD shows when you log in. CELZ Good Day
U.S. securities exchanges are open on Columbus Day: Learn more about trade settlement, account funding, and our hours of operation.
Looks like ALKM is gonna launch its own Tea.
https://trademarks.justia.com/856/65/alkame-85665708.html?fbclid=IwAR0eAIJOtL6kfAcGn9I47qbuvUflPYweZwqWMzA-3j01KqtDZwZqOaraWYI
Bell Food & Beverage Inc.
August 9 ·
A whole new set of teas about to head into production after some pretty rigorous development. Test batch is up next and then they can launch! Very excited to see them on the home stretch.
ALKM 2019-10-04 TEAS SECTION 8 & 15 RECEIVED
https://trademarks.justia.com/856/65/alkame-85665708.html?fbclid=IwAR0eAIJOtL6kfAcGn9I47qbuvUflPYweZwqWMzA-3j01KqtDZwZqOaraWYI
ARYC The Dip is over (sold too early) Get on the train or be left at the station.
ARYC Did you get a pic of the front door with the open sign lit up?
October 2019 Shareholder Update: We Promised, We Delivered
8:15 AM ET 10/10/19 | Dow Jones
PHOENIX, Oct. 10, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today provided shareholder updates.
"The third quarter of 2019 was one of the most productive in our company's history," said Donald Dickerson, CFO of Creative Medical Technology Holdings Inc. "We laid out a roadmap for the back half of the year, and I am proud that we have delivered on all fronts."
"I am thrilled with the effort of our team and am confident the fruit of their labor will come to the
forefront as we close out the year," commented Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc. "I would also like to take a moment to thank our committed shareholders, as we recognize the stock price has not been reflective of the intrinsic value we have built in the company. Please rest assured we remain committed to increasing shareholder value, and believe your patience will be greatly rewarded in the near future."
About Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company currently trading on the OTC under the ticker symbol CELZ. For further information about the company go to www.creativemedicaltechnology.com. For more information on our Caverstem(R) procedure please go to www.caverstem.com.
Forward-Looking Statements
OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov.
View original content to download multimedia:http://www.prnewswire.com/news-releases/october-2019-shareholder-update-we-promised-we-delivered-300936305.html
SOURCE Creative Medical Technology Holdings, Inc.
/Web site: https://creativemedicaltechnology.com/
> Dow Jones Newswires
October 10, 2019 08:15 ET (12:15 GMT)
ARYC 25% pullback after a 2 day 100% run is not bad.
http://bellcampus.com/ Is lookin great! 2 more spots need to be finished.
Our Brands
Company Store
Wow ALKM BID just expanded no one selling 4's
Alkame Holdings, Inc
OTC BBN : ALKM
$0.0005 0.00 (0.00%)
Bid/Ask
0.0004 / 0.0005
B/A Size
62,057,600 X 15,950,800
Volume
3,646,328
ALKM Strong Bid. Need to take out that little on the 5's and move up like the Jeffersons.
Alkame Holdings, Inc.
OTC BBN : ALKM
$0.0005 0.00 (0.00%)
Bid/Ask
0.0004 / 0.0005
B/A Size
45,557,600 X 16,710,800
Volume
2,886,328
CELZ looks like slapman showed up.
Power Hour
ARYC I can agree that it is not working. The Share price keeps going Up. . Need new material or a life.
ARYC someone just lost 900k shares
ALKM ZERO Sells Today.
ARYC We need the SLOAN Report or is that Him on da Bid?